The efficacy and safety of varenicline alone versus in combination with nicotine lozenges for smoking cessation among hospitalised smokers (VANISH): study protocol for a randomised, placebo-controlled trial

INTRODUCTION: Smoking is a leading cause of premature deaths globally. The health benefits of smoking cessation are many. However, majority of quit attempts are unsuccessful. One way to potentially improve success rates is to evaluate new combinations of existing smoking cessation therapies that may...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMJ Open
Auteurs principaux: Gobarani, Rukshar Kaizerali, Abramson, Michael J, Bonevski, Billie, Weeks, Gregory R, Dooley, Michael J, Smith, Brian J, Veale, Antony, Webb, Ashley, Kirsa, Sue, Thomas, Dennis, Miller, Alistair, Gasser, Rudi, Paul, Eldho, Parkinson, Jacqueline, Meanger, Darshana, Coward, Lisa, Kopsaftis, Zoe, Rofe, Olivia, Lee, Paula, George, Johnson
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2020
Sujets:
Smoking and Tobacco
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539569/
https://ncbi.nlm.nih.gov/pubmed/33028555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-038184
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires